Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) | MicrobiomeTrials← Back to trialsNCT07447557
Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-08-07Est. Completion: 2032-12
Enrollment target: 8 participants Locations- Stanford University, Palo Alto, California, United States
- University of Iowa, Iowa City, Iowa, United States
Other microbiome trials you might be interested in
Peripheral NeuropathyNeuro-Degenerative DiseaseNeuromuscular Diseases
This is a multicenter, longitudinal, prospective observational natural history study of subjects with a molecularly conf…
San Francisco, United StatesEst. completion Mar 1, 2031
Charcot-Marie-ToothCMT1AChronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyneuropathy Associated With Anti-MAG Antibodies (Anti-MAG Polyneuropathy)Anti-MAG Neuropathy
The project aims to perform both conventional nerve-conduction studies and axonal-excitability assessments using the TRO…
Milan, ItalyEst. completion May 2026